Literature DB >> 8890251

Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.

A J Szalai1, D E Briles, J E Volanakis.   

Abstract

Expression of a human C-reactive protein (CRP) transgene has been shown to protect mice from lethal Streptococcus pneumoniae infection. In the present study, we used cobra venom factor-induced decomplementation to investigate the role of complement in this CRP-mediated protection. An intact complement system significantly reduced pneumococcal bacteremia at 24 h postinfection and extended median survival time of both CRP-transgenic and nontransgenic mice. However, mortality was significantly lowered only for CRP transgenic mice. The transgene significantly reduced bacteremia for both normocomplementemic and decomplemented mice, but it resulted in a significantly longer median survival time and lower mortality only for normocomplementemic mice. These data suggest that in vivo complement and CRP amplify each other's protective capacity, particularly during the early course of infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890251      PMCID: PMC174457          DOI: 10.1128/iai.64.11.4850-4853.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Opsonizing activity of C-reactive protein in phagocytosis of Aspergillus fumigatus conidia by human neutrophils.

Authors:  M D Richardson; G S Shankland; C A Gray
Journal:  Mycoses       Date:  1991 Mar-Apr       Impact factor: 4.377

2.  Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria.

Authors:  C O Kindmark
Journal:  Clin Exp Immunol       Date:  1971-06       Impact factor: 4.330

3.  C-reactive protein--a phagocytosis-promoting factor.

Authors:  P O Ganrot; C O Kindmark
Journal:  Scand J Clin Lab Invest       Date:  1969-10       Impact factor: 1.713

4.  Solid phase enzyme immunoassays for the quantification of serum amyloid P (SAP) and complement component 3 (C3) proteins in acute-phase mouse sera.

Authors:  Y S Taktak; B Stenning
Journal:  Horm Metab Res       Date:  1992-08       Impact factor: 2.936

5.  Changes in serum concentration and mRNA level of rat C-reactive protein.

Authors:  W Nunomura; Y Takakuwa; T Higashi
Journal:  Biochim Biophys Acta       Date:  1994-10-21

6.  Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice.

Authors:  A J Szalai; D E Briles; J E Volanakis
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

7.  The critical role of complement in experimental pneumococcal sepsis.

Authors:  S W Hosea; E J Brown; M M Frank
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

Review 8.  The role of complement in the host's defense against Streptococcus pneumoniae.

Authors:  J A Winkelstein
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

9.  Opsonic effect of C-reactive protein on phagocytosis and intracellular killing of virulent and attenuated strains of Candida albicans by human neutrophils.

Authors:  M D Richardson; C A Gray; G S Shankland
Journal:  FEMS Microbiol Immunol       Date:  1991-11

10.  C-reactive protein binds to Fc gamma RI in transfected COS cells.

Authors:  L L Marnell; C Mold; M A Volzer; R W Burlingame; T W Du Clos
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

View more
  45 in total

Review 1.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

Review 2.  B1b lymphocyte-derived antibodies control Borrelia hermsii independent of Fcα/μ receptor and in the absence of host cell contact.

Authors:  Matthew J Colombo; David Abraham; Akira Shibuya; Kishore R Alugupalli
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.

Authors:  Y i Hwang; M H Nahm; D E Briles; D Thomas; J M Purkerson
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide.

Authors:  Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson; Alok Agrawal
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

5.  Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins.

Authors:  Ning Zhang; Quynh Ai Truong-Tran; Brian Tancowny; Kathleen E Harris; Robert P Schleimer
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

6.  Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohorts.

Authors:  Sachin Yende; Karina Alvarez; Laura Loehr; Aaron R Folsom; Anne B Newman; Lisa A Weissfeld; Richard G Wunderink; Stephen B Kritchevsky; Kenneth J Mukamal; Stephanie J London; Tamara B Harris; Doug C Bauer; Derek C Angus
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

7.  Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice.

Authors:  A J Szalai; J L VanCott; J R McGhee; J E Volanakis; W H Benjamin
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 8.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 9.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

10.  CRP gene variation and risk of community-acquired pneumonia.

Authors:  Kenneth J Mukamal; Jennifer K Pai; Ellen S O'Meara; Russell P Tracy; Bruce M Psaty; Lewis H Kuller; Anne B Newman; Sachin Yende; Gary C Curhan; David S Siscovick; Eric B Rimm
Journal:  Respirology       Date:  2009-11-23       Impact factor: 6.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.